Can Novarel reduce the likelihood of premature luteinization during ovarian stimulation, and what are the potential benefits for cycle outcomes?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Novarel reduce the likelihood of premature luteinization during ovarian stimulation, and what are the potential benefits for cycle outcomes?
Novarel, a brand of hCG, is used in IVF cycles to prevent premature luteinization, potentially improving outcomes by ensuring better egg quality and maturity.
Novarel can prevent premature luteinization during ovarian stimulation, potentially improving egg quality and increasing pregnancy rates.